AI assistant
InspireMD, Inc. — Director's Dealing 2021
Feb 10, 2021
34187_dirs_2021-02-10_085a9f00-83ad-4f03-8933-85b5877e810e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2021-02-08
Reporting Person: ROUBIN GARY S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-08 | Common Stock | P | 241930 | $0.62 | Acquired | 703103 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-08 | Warrants | $0.682 | P | 120965 | Acquired | 2026-02-08 | Common Stock (120965) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Purchase Common Stock | $0.33 | 2030-10-12 | Common Stock (79650) | 79650 | Direct |
Footnotes
F1: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 241,930 shares of common stock and warrants to purchase 120,965 shares of common stock together, as part of 241,930 units, at a purchase price of $0.62 per unit.
F2: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F3: These options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 12, 2021, October 12, 2022 and October 12, 2023, subject to the Reporting Person's continued service.